查看文章

As has been reported previously in the Journal, 1 novel psychoactive stimulant drugs are now increasingly prevalent in patients presenting to hospital emergency departments. A further cluster of 11 patients showing confusing hallmarks of sympathomimetic poisoning but no identifiable substance presented to St Vincents Hospital in Sydney over a public holiday weekend in April 2015. Also, the start to the 2015–2016 summer festival season has included multiple deaths and hospitalisations following drug use at festivals, leading to calls for novel actions to protect public health. 2 Here, we take the opportunity to describe a method of harm-minimisation that has been deployed in Europe and could potentially be deployed locally to tackle this problem.